Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venture Life ( (GB:VLG) ) just unveiled an announcement.
Venture Life Group has repurchased 102,342 ordinary shares at a volume-weighted average price of 68.52 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 shares in issue, of which 6,382,768 are held in treasury, reducing the total voting rights to 122,477,377 and modestly increasing existing shareholders’ proportional ownership.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on VLG Stock
According to Spark, TipRanks’ AI Analyst, VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on VLG stock, click here.
More about Venture Life
Venture Life Group is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector. Its portfolio spans women’s intimate health, ENT care, energy and glucose management, and hormonal lifecycle support, with products sold through pharmacies, health and beauty chains, grocery multiples and e-commerce, both directly in key markets and via distributors elsewhere.
Average Trading Volume: 303,339
Technical Sentiment Signal: Buy
Current Market Cap: £83.97M
For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.